Developer of predictive toxicology products. The company is a drug discovery pharmacogenomics company focused on predicting human safety earlier. It combines groundbreaking human cell culture and genomic modelling to produce high throughput screens for use alongside other early ADME testing.
Missing: SimuGen's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: SimuGen's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
SimuGen Frequently Asked Questions (FAQ)
When was SimuGen founded?
SimuGen was founded in 2005.
Where is SimuGen's headquarters?
SimuGen's headquarters is located at 83 Victoria Street, London.
What is SimuGen's latest funding round?
SimuGen's latest funding round is Grant - II.
How much did SimuGen raise?
SimuGen raised a total of $280K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.